71 West Capital Partners

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2111530 BOSTON, MA

Position in VRTX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$939,813

+$244,104 QoQ

Shares Held

1,892

+21.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#873

of 1,735 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

71 West Capital Partners holds $3,182,250 across 4 Biotechnology names. VRTX ranks #2 (29.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	43,164	$1,527,573
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,892	$939,813
3	VRDN	Viridian Therapeutics, Inc.\DE	21,400	$393,118
4	REGN	Regeneron Pharmaceuticals, Inc.	516	$321,746

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$939,813	1,892	+21.4%	Shares	Sole	2026-08-04
2026-03-31	$695,709	1,558	+29.8%	Shares	Sole	2026-05-06
2025-12-31	$544,032	1,200	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.